In conclusion, our findings suggested that FXR exerted a tumor-suppressive effect in HCC by inhibiting the phosphorylation of STAT3 in HCC stem cells through targeting SOCS3 (Figure 8). The gene discussed is STAT3; the disease is neoplasm.